Keyword: Anemia , Drug Industry , Drug Therapy, Combination , Hospitals, University , Hepatitis C , Product Surveillance, Postmarketing , Skin Diseases , Ribavirin , Treatment Outcome , Hyperuricemia , Renal Insufficiency , Medication Adherence , Telaprevir pp.663-667
Published Date 2014/4/1
DOI https://doi.org/10.15106/J00974.2014127385

©Nankodo Co., Ltd., 2014

基本情報

電子版ISSN 2432-9452 印刷版ISSN 0022-1961 南江堂

関連文献

もっと見る

文献を共有